Related Experiment Video
Updated: Jun 4, 2026
10:13
Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia
Published on: July 31, 2017
Neuroprotective actions of flavonoids
C Gutierrez-Merino1, C Lopez-Sanchez, R Lagoa
1Dept. Biochemistry and Molecular Biology, Faculty of Sciences, University of Extremadura, Avenida de Elvas s/n, 06006 - Badajoz, Spain. carlosgm@unex.es
Current Medicinal Chemistry
|February 5, 2011
Summary
Flavonoids combat neurodegeneration by reducing oxidative stress through direct antioxidant action or pathway modulation. Their metabolites also offer antioxidant benefits, but brain bioavailability and specific reactive oxygen species (ROS) must be considered for effective therapies.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Oxidative stress is a key factor in neurodegeneration.
- Flavonoids act as antioxidants, directly or by modulating cellular pathways.
- Flavonoid metabolism produces bioactive antioxidant derivatives.
Purpose of the Study:
- To review neuroprotection by various flavonoids in cellular and animal models.
- To discuss the role of flavonoid metabolites in antioxidant therapy.
- To consider brain bioavailability and specific reactive oxygen species (ROS) in neurodegenerative diseases.
Main Methods:
- Literature review of neuroprotection studies involving flavonoids.
- Analysis of flavonoid metabolism and metabolite bioactivity.
- Discussion of administration protocols and ROS involvement in neurodegeneration.
Main Results:
- Flavonoids demonstrate neuroprotective effects through multiple antioxidant mechanisms.
- Flavonoid metabolites retain significant antioxidant and neuroprotective potential.
- Optimizing flavonoid therapy requires considering brain penetration and disease-specific ROS.
Conclusions:
- Flavonoids show promise for treating neurodegenerative diseases due to their antioxidant properties.
- Further research into flavonoid bioavailability and targeted ROS modulation is crucial for therapeutic development.
- Flavonoids exhibit low toxicity, supporting their potential as pharmacological agents.
Related Concept Videos
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
01:14Antiepileptic Drugs: Glutamate Antagonists
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...